Endo International plc Quarterly Nonoperating Income (Expense) in USD from Q3 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Endo International plc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2015 to Q4 2023.
  • Endo International plc Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $7.53M, a 36.8% decline year-over-year.
  • Endo International plc Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $9.69M, a 71.6% decline year-over-year.
  • Endo International plc annual Nonoperating Income (Expense) for 2023 was $9.69M, a 71.6% decline from 2022.
  • Endo International plc annual Nonoperating Income (Expense) for 2022 was $34.1M, a 72.2% increase from 2021.
  • Endo International plc annual Nonoperating Income (Expense) for 2021 was $19.8M, a 6.33% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $9.69M $7.53M -$4.38M -36.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $14.1M $2.22M -$1.78M -44.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $15.9M -$179K -$19.6M -101% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $35.5M $125K +$1.41M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $34.1M $11.9M -$3.2M -21.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $37.3M $4M -$1.96M -32.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $39.2M $19.4M +$19.8M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $19.4M -$1.29M -$377K -41.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $19.8M $15.1M +$19.3M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $463K $5.96M -$1.24M -17.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.7M -$372K -$4.52M -109% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $6.22M -$912K -$14.9M -107% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $21.1M -$4.21M -$7.94M -213% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $29M $7.19M +$23.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $5.65M $4.15M +$3.55M +595% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $2.1M $14M +$18.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$16.7M $3.73M -$15M -80.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$1.67M -$16.2M -$17.7M -1175% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $16M $597K -$28.2M -97.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $44.3M -$4.8M -$7.68M -267% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $52M $18.7M +$12.6M +203% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $39.4M $1.51M -$590K -28.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $40M $28.8M +$22.1M +330% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $17.9M $2.88M +$841K +41.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $17M $6.18M +$5.44M +735% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $11.6M $2.1M -$769K -26.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $12.4M $6.71M +$11.9M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $468K $2.04M +$130K +6.82% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $338K $740K Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $2.87M +$53M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.18M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.91M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 -$50.1M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.